Insulet to Present at Upcoming Investor Conferences
15 November 2024 - 10:00PM
Business Wire
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader
in tubeless insulin pump technology with its Omnipod® brand of
products, today announced that management will present at three
upcoming investor conferences (all Eastern Time):
- The 6th Annual Wolfe Research Healthcare Conference in New York
City on Wednesday, November 20, 2024 at 12:00 p.m.
- The Nasdaq 51st Investor Conference in London on Tuesday,
December 10, 2024 at 5:30 a.m.
- The J.P. Morgan 43rd Annual Healthcare Conference in San
Francisco on Tuesday, January 14, 2025 at 6:45 p.m.
To listen to the live audio webcasts of the presentations,
please visit investors.insulet.com/events. Replays of the webcasts
will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in
Massachusetts, is an innovative medical device company dedicated to
simplifying life for people with diabetes and other conditions
through its Omnipod product platform. The Omnipod Insulin
Management System provides a unique alternative to traditional
insulin delivery methods. With its simple, wearable design, the
tubeless disposable Pod provides up to three days of non-stop
insulin delivery, without the need to see or handle a needle.
Insulet’s flagship innovation, the Omnipod 5 Automated Insulin
Delivery System, integrates with a continuous glucose monitor to
manage blood sugar with no multiple daily injections, zero
fingersticks, and can be controlled by a compatible personal
smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also
leverages the unique design of its Pod by tailoring its Omnipod
technology platform for the delivery of non-insulin subcutaneous
drugs across other therapeutic areas. For more information, please
visit insulet.com and omnipod.com.
©2024 Insulet Corporation. Omnipod is a registered trademark of
Insulet Corporation. All rights reserved. All other trademarks are
the property of their respective owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241115947479/en/
Investor Relations: Deborah R. Gordon Vice President,
Investor Relations (978) 600-7717 dgordon@insulet.com
Media: Angela Geryak Wiczek Senior Director, Corporate
Communications (978) 932-0611 awiczek@insulet.com
Insulet (NASDAQ:PODD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Insulet (NASDAQ:PODD)
Historical Stock Chart
From Nov 2023 to Nov 2024